Literature DB >> 322563

Bacteroides fragilis subspecies in clinical isolates.

B F Polk, D L Kasper.   

Abstract

Isolates of Bacteroides fragilis from 83 infected patients were collected during 2 years. Of 103 isolates, 68% were subspecies fragilis. This was the single most common subspecies isolated from blood (12/17), intra-abdominal (11/28), wound (17/20), perirectal (11/16), pelvic (6/10), and other (8/11) sites. Sixteen patients had B. fragilis isolated in pure culture. Of these, 9/12 blood cultures and 4/4 cultures from other sites were ss. fragilis. The recent observation that ss. fragilis organisms are encapsulated whereas the other subspecies are generally unencapsulated was supported by indirect fluorescent antibody studies using antibodies prepared to the capsular material of ss. fragilis. All 33 strains of ss. fragilis and none of 13 strains of other subspecies were positive. The predominance of ss. fragilis in clinical isolates compared to its relative infrequency in normal fecal flora and its predominance in pure cultures, especially of blood, indicate that this is the most virulent of B. fragilis subspecies. This virulence may be related to encapsulation.

Entities:  

Mesh:

Year:  1977        PMID: 322563     DOI: 10.7326/0003-4819-86-5-569

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  79 in total

Review 1.  The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA.

Authors:  Neeraj K Surana; Dennis L Kasper
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

2.  Adaptive immune defects against glycoantigens in chronic granulomatous disease via dysregulated nitric oxide production.

Authors:  Colleen J Lewis; Brian A Cobb
Journal:  Eur J Immunol       Date:  2011-08-04       Impact factor: 5.532

3.  Orientations of the Bacteroides fragilis capsular polysaccharide biosynthesis locus promoters during symbiosis and infection.

Authors:  Erin B Troy; Vincent J Carey; Dennis L Kasper; Laurie E Comstock
Journal:  J Bacteriol       Date:  2010-08-20       Impact factor: 3.490

4.  Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis.

Authors:  A Pantosti; A O Tzianabos; A B Onderdonk; D L Kasper
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

5.  Structure-function relationships for polysaccharide-induced intra-abdominal abscesses.

Authors:  A O Tzianabos; A B Onderdonk; R S Smith; D L Kasper
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Diverse Intestinal Bacteria Contain Putative Zwitterionic Capsular Polysaccharides with Anti-inflammatory Properties.

Authors:  C Preston Neff; Matthew E Rhodes; Kathleen L Arnolds; Colm B Collins; Jody Donnelly; Nichole Nusbacher; Paul Jedlicka; Jennifer M Schneider; Martin D McCarter; Michael Shaffer; Sarkis K Mazmanian; Brent E Palmer; Catherine A Lozupone
Journal:  Cell Host Microbe       Date:  2016-09-29       Impact factor: 21.023

Review 7.  Microbiota and autoimmunity.

Authors:  Alexander V Chervonsky
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-03-01       Impact factor: 10.005

8.  Evaluation of the biomed bacteroides IF kit for identification of Bacteroides fragilis group strains.

Authors:  A Vege; T Hofstad; A Sawicka-Grzelak; H Pituch; F Meisel-Mikolajczyk
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

Review 9.  Bacterial oncogenesis in the colon.

Authors:  Christine Dejea; Elizabeth Wick; Cynthia L Sears
Journal:  Future Microbiol       Date:  2013-04       Impact factor: 3.165

10.  The capsular polysaccharide complex of Bacteroides fragilis induces cytokine production from human and murine phagocytic cells.

Authors:  F C Gibson; A O Tzianabos; A B Onderdonk
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.